Research Progress on Prognosis Assessment of Community-acquired Pneumonia

doi:10.12114/j.issn.1007-9572.2019.00.367

Abstract

Abstract: Community-acquired pneumonia（CAP）is one of the major challenges faced by clinicians.CAP severity grading is the basis for patients to choose appropriate treatment sites and reasonable antibiotic treatment，so it is of great significance to identify and assess comprehensively the severity of CAP at an early stage.Early assessment and active intervention of high-risk patients requiring hospitalization or admission to the intensive care unit（ICU） using clinical scoring systems and/or biomarkers can improve the survival and achieve more effective allocation of medical resources.This article reviews the recent progress in the evaluation of different scoring systems and biomarkers in the prognosis of patients with CAP.

Key words: Community-acquired pneumonia, Score scale, Biological markers, Intensive care units, Prognosis, Neutrophil-lymphocyte ratio, Mid-regional pro-adrenomedullin, Red blood cell distribution width

摘要： 社区获得性肺炎（CAP）是临床医生面临的艰巨挑战之一。CAP严重程度分级是患者选择恰当的治疗场所及合理抗生素治疗的基础，故早期识别、全面评估CAP严重程度具有重要意义。使用临床评分系统和/或生物标志物对需要住院治疗或入住重症监护病房（ICU）的高危患者进行早期评估并积极干预可改善生存期并实现更有效的医疗资源分配。本文对近年不同评分系统及生物标志物在CAP患者预后中评估作用的研究进展进行综述。
社区获得性肺炎；评分量表；生物学标记；重症监护病房；预后；中性粒细胞/淋巴细胞比值；肾上腺髓质素前体中段肽；红细胞体积分布宽度

WANG Lina,JIANG Chunyan. Research Progress on Prognosis Assessment of Community-acquired Pneumonia　[J]. Chinese General Practice, 2020, 23(14): 1711-1716. DOI: 10.12114/j.issn.1007-9572.2019.00.367.
王丽娜,姜春燕. 社区获得性肺炎预后评估的研究进展[J]. 中国全科医学, 2020, 23(14): 1711-1716. DOI: 10.12114/j.issn.1007-9572.2019.00.367.

References

［1］中华医学会呼吸病学分会.中国成人社区获得性肺炎诊断和治疗指南（2016年版）［J］．中华结核和呼吸杂志，2016，39（4）：253-279．DOI：10.3760/cma.j.issn.1001-0939.2016.04.005.
Chinese Thoracic Society.Guidelines for the diagnosis and treatment of adult community-acquired pneumonia in China（2016 edition）［J］．Chinese Journal of Tuberculosis and Respiratory Diseases，2016，39（4）：253-279．DOI：10.3760/cma.j.issn.1001-0939.2016.04.005.
［2］AKHTER S，RIZVI N，BHURA S，et al．Management of community acquired pneumonia by family physicians［J］．Pak J Med Sci，2017，33（4）：783-787．DOI：10.12669/pjms.334.12577.
［3］RAMIREZ J A，WIEMKEN T L，PEYRANI P，et al．Adults hospitalized with pneumonia in the United States：incidence，epidemiology，and mortality［J］．Clin Infect Dis，2017，65（11）：1806-1812．DOI：10.1093/cid/cix647.
［4］GBD 2013 Mortality and Causes of Death Collaborators.Global，regional，and national age-sex specific all-cause and cause-specific mortality for 240 causes of death，1990—2013：a systematic analysis for the Global Burden of Disease Study 2013［J］．Lancet，2015，385（9963）：117-171．DOI：10.1016/S0140-6736（14）61682-2.
［5］刘慧，肖新才，陆剑云，等．2009—2012年广州市社区获得性肺炎流行特征和病原学研究［J］．中华预防医学杂志，2013，47（12）：1089-1094．DOI：10.3760/cma.j.issn.0253-9624.2013.12.005.
LIU H，XIAO X C，LU J Y，et al．Study on epidemic characteristics and etiology of community acquired pneumonia in Guangzhou from 2009 to 2012［J］．Chinese Journal of Preventive Medicine，2013，47（12）：1089-1094．DOI：10.3760/cma.j.issn.0253-9624.2013.12.005.
［6］FINE M J，AUBLE T E，YEALY D M，et al．A prediction rule to identify low-risk patients with community-acquired pneumonia［J］．N Engl J Med，1997，336（4）：243-250．DOI：10.1056/NEJM199701233360402.
［7］MARRIE T J.Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia［J］．Chemotherapy，2004，50（Suppl 1）：11-15．DOI：10.1159/000079817.
［8］MARTI C，GARIN N，GROSGURIN O，et al．Prediction of severe community-acquired pneumonia：a systematic review and meta-analysis［J］．Crit Care，2012，16（4）：R141．DOI：10.1186/cc11447.
［9］MARCOS P J，RESTREPO M I，GONZáLEZ-BARCALA F J，et al．
Discordance of physician clinical judgment vs.pneumonia severity index（PSI） score to admit patients with low risk community-acquired pneumonia：a prospective multicenter study［J］．J Thorac Dis，2017，9（6）：1538-1546．DOI：10.21037/jtd.2017.05.44.
［10］KWOK C S，LOKE Y K，WOO K，et al．Risk prediction models for mortality in community-acquired pneumonia：a systematic review［J］．Biomed Res Int，2013，2013：504136．DOI：10.1155/2013/504136.
［11］LIU J L，XU F，ZHOU H，et al．Expanded CURB-65：a new score system predicts severity of community-acquired pneumonia with superior efficiency［J］．Sci Rep，2016，6：22911．DOI：10.1038/srep22911.
［12］BERMEJO-MARTIN J F，CILLONIZ C，MENDEZ R，et al．Lymphopenic community acquired pneumonia（L-CAP），an immunological phenotype associated with higher risk of mortality［J］．EBioMedicine，2017，24：231-236．DOI：10.1016/j.ebiom.2017.09.023.
［13］CHARLES P G，WOLFE R，WHITBY M，et al．SMART-COP：a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia［J］．Clin Infect Dis，2008，47（3）：375-384．DOI：10.1086/589754.
［14］ROBINS-BROWNE K L，CHENG A C，THOMAS K A，et al．The SMART-COP score performs well for pneumonia risk stratification in Australia's Tropical Northern Territory：a prospective cohort study［J］．Trop Med Int Health，2012，17（7）：914-919．DOI：10.1111/j.1365-3156.2012.03006.x.
［15］WILLIAMS E，GIRDWOOD J，JANUS E，et al．CORB is the best pneumonia severity score for elderly hospitalised patients with suspected pneumonia［J］．Intern Med J，2014，44（6）：613-615．DOI：10.1111/imj.12445.
［16］TOKIOKA F，OKAMOTO H，YAMAZAKI A，et al．The prognostic performance of qSOFA for community-acquired pneumonia［J］．J Intensive Care，2018，6：46．DOI：10.1186/s40560-018-0307-7.
［17］FELDMAN C，ANDERSON R.Pneumonia as a systemic illness［J］．Curr Opin Pulm Med，2018，24（3）：237-243．DOI：10.1097/MCP.0000000000000466.
［18］FERNANDES L，ARORA A S，MESQUITA A M.Role of semi-quantitative serum procalcitonin in assessing prognosis of community acquired bacterial pneumonia compared to PORT PSI，CURB-65 and CRB-65［J］．J Clin Diagn Res，2015，9（7）：OC01-OC04．DOI：10.7860/JCDR/2015/12468.6147.
［19］KIM M W，LIM J Y，OH S H.Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia［J］．Scand J Clin Lab Invest，2017，77（7）：486-492．DOI：10.1080/00365513.2017.1344298.
［20］中国医药教育协会感染疾病专业委员会.感染相关生物标志物临床意义解读专家共识［J］．中华结核和呼吸杂志，2017，40（4）：243-257．DOI：10.3760/cma.j.issn.1001-0939.2017.04.002.
China Medical Education Association Infectious Diseases Professional Committee.Expert consensus on the interpretation of clinical significance of infection-related biomarkers［J］．Chinese Journal of Tuberculosis and Respiratory Diseases，2017，40（4）：243-257．DOI：10.3760/cma.j.issn.1001-0939.2017.04.002.
［21］BERMEJO-MARTIN J F，ALMANSA R，MARTIN-FERNANDEZ M，et al．Immunological profiling to assess disease severity and prognosis in community-acquired pneumonia［J］．Lancet Respir Med，2017，5（12）：e35-36．DOI：10.1016/S2213-2600（17）30444-7.
［22］CATAUDELLA E，GIRAFFA C M，DI MARCA S，et al．
Neutrophil-to-lymphocyte ratio：an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia［J］．J Am Geriatr Soc，2017，65（8）：1796-1801．DOI：10.1111/jgs.14894.
［23］LEGRAMANTE J M，MASTROPASQUA M，SUSI B，et al．Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the emergency department compared to clinical severity scores PSI and CURB［J］．PLoS One，2017，12（11）：e0187702．DOI：10.1371/journal.pone.0187702.
［24］LIPPI G，DIPALO M，TETI L，et al．Relationship between red blood cell distribution width and prognostic biomarkers in patients admitted to the emergency department with acute infections［J］．Eur J Intern Med，2013，24（2）：e15-16．DOI：10.1016/j.ejim.2012.09.005.
［25］BRAUN E，DOMANY E，KENIG Y，et al．Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia［J］．Crit Care，2011，15（4）：R194．DOI：10.1186/cc10355.
［26］LEE J H，CHUNG H J，KIM K，et al．Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia［J］．Am J Emerg Med，2013，31（1）：72-79．DOI：10.1016/j.ajem.2012.06.004.
［27］BELLO S，FANDOS S，LASIERRA A B，et al．Red blood cell distribution width［RDW］and long-term mortality after community-acquired pneumonia.A comparison with proadrenomedullin［J］．Respir Med，2015，109（9）：1193-1206．DOI：10.1016/j.rmed.2015.07.003.
［28］LEE S M，LEE J H，KIM K，et al．The clinical significance of changes in red blood cell distribution width in patients with community-acquired pneumonia［J］．Clin Exp Emerg Med，2016，3（3）：139-147．DOI：10.15441/ceem.15.081.
［29］KIM J W，HONG D Y，LEE K R，et al．Usefulness of plasma neutrophil gelatinase-associated lipocalin concentration for predicting the severity and mortality of patients with community-acquired pneumonia［J］．Clin Chim Acta，2016，462：140-145．DOI：10.1016/j.cca.2016.09.011.
［30］VESTJENS S M T，SPOORENBERG S M C，RIJKERS G T，et al．High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia［J］．Respirology，2017，22（5）：1000-1006．DOI：10.1111/resp.12996.
［31］LIU J L，WU X J，LU F，et al．Low T3 syndrome is a strong predictor of poor outcomes in patients with community-acquired pneumonia［J］．Sci Rep，2016，6：22271．DOI：10.1038/srep22271.
［32］SABALLS M，PARRA S，SAHUN P，et al．HDL-C levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia［J］．Springerplus，2016，5（1）：1491．DOI：10.1186/s40064-016-3145-x.
［33］TOKGOZ AKYIL F，YALCINSOY M，HAZAR A，et al．Prognosis of hospitalized patients with community-acquired pneumonia［J］．Pulmonology，2018，24（3）：164-169．DOI：10.1016/j.rppnen.2017.07.010.
［34］ITO A，ISHIDA T，TOKUMASU H，et al．Prognostic factors in hospitalized community-acquired pneumonia：a retrospective study of a prospective observational cohort［J］．BMC Pulm Med，2017，17（1）：78．DOI：10.1186/s12890-017-0424-4.
［35］YEON LEE S，CHA S I，SEO H，et al．Multimarker prognostication for hospitalized patients with community-acquired pneumonia［J］．Intern Med，2016，55（8）：887-893．DOI：10.2169/internalmedicine.55.5764.
［36］BITEKER F S，BITEKER M，BASARAN ?，et al．A small pericardial effusion is a marker of complicated hospitalization in patients with community-acquired pneumonia［J］．J Crit Care，2018，44：294-299．DOI：10.1016/j.jcrc.2017.11.030.
［37］OZMEN I，KARAKURT Z，SALTURK C，et al．Can N-terminal pro B-type natriuretic peptide，neutrophil-to-lymphocyte ratio，C-reactive protein help to predict short and long term mortality?［J］．Bratisl Lek Listy，2016，117（10）：587-594.
［38］IQBAL N，IRFAN M，ZUBAIRI A B S，et al．Association of hypercapnia on admission with increased length of hospital stay and severity in patients admitted with community-acquired pneumonia：a prospective observational study from Pakistan［J］．BMJ Open，2017，7（6）：e013924．DOI：10.1136/bmjopen-2016-013924.
［39］KOLDITZ M，BRAEKEN D，EWIG S，et al．Severity assessment and the immediate and long-term prognosis in community-acquired pneumonia［J］．Semin Respir Crit Care Med，2016，37（6）：886-896．DOI：10.1055/s-0036-1592127.

[1]	XU Yanpeng, HUANG Pe, ZHANG Pingping, LUO Yan, SHI Xiaoqi, WU Liusong, CHEN Yan, HE Zhixu. Expression of β-Adrenergic Receptors in Acute T-cell Lymphoblastic Leukemia and Its Clinical Significance [J]. Chinese General Practice, 2025, 28(27): 3391-3398.
[2]	YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058.
[3]	CHEN Fei, WANG Jinying, YU Haibo, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, ZHANG Tianyu, HUANG Zhongxia. Significance of Elevated Urinary NGAL, TIM-1, VCAM-1 and Activin A in Patients with New Diagnosed Multiple Myeloma [J]. Chinese General Practice, 2025, 28(22): 2740-2749.
[4]	YANG Jiang, LI Jiansheng, CHEN Yaolong, LIU Huiguo, WANG Jianxin, YU Jiajie, LI Huiru, XIAO Qionghua, XIE Yang, LI Suyun, WANG Minghang. Guideline on Treating Adult Community-acquired Pneumonia with Chinese Patent Medicines (2025 Edition) [J]. Chinese General Practice, 2025, 28(20): 2464-2480.
[5]	CAO Gan, DENG Yifan, HE Shenghu, ZHANG Jing. Study on the Correlation between the Lactate Dehydrogenase-to-albumin Ratio and Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction after Emergency PCI [J]. Chinese General Practice, 2025, 28(15): 1878-1883.
[6]	ZHANG Shujing, SUN Lixin, CAO Yuqing. Comparative Study on the Clinicopathological Features and Prognostic between HPV-related and Non-HPV-related Cervical Adenocarcinoma [J]. Chinese General Practice, 2025, 28(14): 1758-1764.
[7]	WANG Dexiang, YUAN Jiawen, LU Qinyun, HANG Yuhao, LU Jun, CHENG Lu. Influences of Treatment Timing of the TCM prescription Qingfei Huayu Tongfu Formula on the Therapeutic Effect and Prognosis of Sepsis-related Acute Respiratory Distress Syndrome [J]. Chinese General Practice, 2025, 28(12): 1500-1505.
[8]	LI Qiujing, SHANG Na, GAO Qian, YANG Li, GUO Shubin. Predictive Value of Abdominal CT Based-skeletal Muscle Mass Combined with Critical Illness Score for Prognosis in Older Patients with Intra-abdominal Sepsis [J]. Chinese General Practice, 2025, 28(12): 1459-1464.
[9]	ZHANG Pei, YANG Meng, GAO Chunlin, XIA Zhengkun. Study on the Intervention and Prognosis of Modified Lifting Powder on Acute Kidney Injury and Acute Kidney Disease in Children [J]. Chinese General Practice, 2025, 28(11): 1376-1382.
[10]	WANG Yiquan, CHEN Wanjia, LIU Wangyi, ZHANG Luyun, DENG Yueyi. The Prognosis of Stage 4 Chronic Kidney Diseasetreated with Fermented Cordyceps Sinensis Powder: Based on a Retrospective Cohort Study [J]. Chinese General Practice, 2025, 28(09): 1084-1091.
[11]	DU Huijie, LIU Xingyu, XU Minghuan, YANG Xuezhi, ZHANG Huiqin, MO Jiali, LU Yi, KUANG Jie. Advances in the Prognostic Prediction of Acute Ischemic Stroke: Using Machine Learning Predictive Models as an Example [J]. Chinese General Practice, 2025, 28(05): 554-560.
[12]	ZHANG Pingshu, XUE Jing, XING Aijun, WANG Lianhui, MA Qian, FU Yongshan, YUAN Xiaodong. Study on Sleep Status and Prognostic Factors in Patients with Acute Posterior Circulation Ischemic Stroke [J]. Chinese General Practice, 2025, 28(05): 548-553.
[13]	ZHANG Shaotong, WANG Bo, ZHANG Mingrui, MA Guiyan, LIU Shaoguang. Identification of Sepsis Subphenotypes and Risk Stratification Using the Procalcitonin Trajectory [J]. Chinese General Practice, 2025, 28(05): 594-600.
[14]	ZHU Lu, AI Jun, LIAO Shengwu, HUANG Shuting, GONG Nirong, KONG Yaozhong, LIU Dehui, DOU Xianrui, ZHANG Guangqing. Association of Prognostic Nutritional Index with Cardiovascular Mortality in Patients with Peritoneal Dialysis: a Multicenter Retrospective Cohort Study [J]. Chinese General Practice, 2025, 28(05): 568-574.
[15]	ZHANG Lianfang, ZHENG Yabin, LIN Xuefeng, XIE Rongcheng, MA Jiefei. Clinical Predictive Value of Immature Platelet Fraction Combined with Other Biomarkers for the Severity and Prognosis of Sepsis [J]. Chinese General Practice, 2024, 27(35): 4417-4425.